New Delhi: Researchers from all over the world are busy making the Coronavirus vaccine. Various stages of vaccine trials are underway in many countries. Meanwhile, drug company FDC has launched PiFLU and Favenza, two variants of Favipiravir effective in treating the corona epidemic in India. Its use has been approved for the treatment of patients with mild and moderate symptoms of corona.
FDC Limited has fixed the price of both these variants of Favipiravir at just Rs 55 per tablet. The Drug Controller General of India has approved the antiviral drug Favipiravir. It has been shown to be helpful in the recovery of corona patients with mild and moderate symptoms. FDC spokesman Mayank Tikkha has said that thousands of new cases of corona infections are being registered every day across the country.
PiFLU and Fevenza will help prevent deteriorating health of patients. Together with the government and health sector, we will provide these two medicines all over the country. Favipiravir is an anti-viral enzyme that specifically inhibits RNA polymerase and viral replication of influenza and SARCov-2 viruses.
Also Read:
Ban on religious-social events till 30 September in UP, orders CM Yogi
Conducting JEE-NEET exam amid Corona epidemic is government's dogma: Sachin Pilot
India Open and Syed Modi International tournament canceled due to Corona
